Q1 2022 Holdings
Filed 2022-05-20 | 70 holdings | $443.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| 2Seventy BIO Inc-w/I(TSVT*) | COMMON STOCK | 901384107 | $94 | 3,666 | 0.0% |
| Nkarta(NKTX) | COM | 65487U108 | $209 | 10,034 | 0.0% |
| Seagen(SGENUSD) | COM | 81181C104 | $225 | 76,200 | 0.1% |
| Biomarin Pharm.(BMRN) | COM | 09061G101 | $235 | 79,656 | 0.1% |
| Guardant Health(GH) | COM | 40131M109 | $271 | 74,500 | 0.1% |
| Anaptysbio(ANAB) | COM | 032724106 | $348 | 10,000 | 0.1% |
| Intellia Therapeutics(NTLA) | COM | 45826J105 | $511 | 24,000 | 0.1% |
| PTC Therapeutics(PTCT) | COM | 69366J200 | $617 | 411,000 | 0.1% |
| Agios Pharms.(AGIO) | COM | 00847X104 | $707 | 21,500 | 0.2% |
| Relmada Therapeutics(RLMD) | COM | 75955J402 | $741 | 10,000 | 0.2% |
| Allogene Therapeutics(ALLO) | COM | 019770106 | $747 | 50,000 | 0.2% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $833 | 82,741 | 0.2% |
| Immunovant(IMVT) | COM | 45258J102 | $851 | 60,000 | 0.2% |
| Blueprint Medicines(2L9) | COM | 09627Y109 | $881 | 19,500 | 0.2% |
| Oric Pharms.(ORIC) | COM | 68622P109 | $905 | 176,217 | 0.2% |
| Gilead Sciences(GILD) | COM | 375558103 | $1.1K | 88,784 | 0.2% |
| Amicus Therapeutics(FOLD) | COM | 03152W109 | $1.1K | 94,600 | 0.2% |
| Krystal Biotech(KRYS) | COM | 501147102 | $1.1K | 45,000 | 0.2% |
| Dyne Therapeutics(DYN) | COM | 26818M108 | $1.2K | 476,000 | 0.3% |
| Chemocentryx(CCXIEUR) | COM | 16383L106 | $1.3K | 36,100 | 0.3% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $1.4K | 188,500 | 0.3% |
| Springworks Therapeutics | COM | 85205L107 | $1.4K | 16,300 | 0.3% |
| Apellis Pharms.(APLS) | COM | 03753U106 | $1.5K | 32,500 | 0.3% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $1.6K | 380,000 | 0.3% |
| Ideaya Biosciences(IDYA) | COM | 45166A102 | $1.6K | 109,000 | 0.4% |
| Gbl. Blood Therapeutics | COM | 37890U108 | $1.6K | 151,800 | 0.4% |
| Ascendis Pharma ADR(ASND) | Sponsored ADR | 04351P101 | $2.0K | 29,400 | 0.4% |
| Ultragenyx Pharm.(RARE) | COM | 90400D108 | $2.1K | 233,100 | 0.5% |
| Black Diamond Therapeutic | COM | 0920E3105 | $2.1K | 44,000 | 0.5% |
| Regeneron Pharms.(REGN) | COM | 75886F107 | $2.2K | 12,100 | 0.5% |
| I-Mab(NBP) | SPONSORED ADS | 44975P103 | $2.4K | 18,000 | 0.5% |
| Incyte(INCY) | COM | 45337C102 | $2.6K | 238,000 | 0.6% |
| Harpoon Therapeutics | COM | 41358P106 | $2.8K | 151,445 | 0.6% |
| Iovance Biotherapeutics(IOVA) | COM | 462260100 | $2.8K | 58,000 | 0.6% |
| Utd. Therapeutics(UTHR) | COM | 91307C102 | $2.9K | 20,000 | 0.7% |
| Neurocrine Biosciences(NBIX) | COM | 64125C109 | $3.1K | 203,000 | 0.7% |
| Xenon Pharmaceuticals Inc NPV(XENE) | COM | 98420N105 | $3.2K | 25,500 | 0.7% |
| Vertex Pharms.(VRTX) | COM | 92532F100 | $3.2K | 25,122 | 0.7% |
| Ionis Pharms.(IONS) | COM | 462222100 | $3.3K | 154,088 | 0.7% |
| Aurinia Pharmaceuticals Inc Com NPV(AUPH) | COM | 05156V102 | $4.0K | 435,000 | 0.9% |
| Chinook Therapeutics(290A) | COM | 16961L106 | $4.7K | 340,389 | 1.1% |
| Madrigal Pharms.(MDGL) | COM | 558868105 | $5.1K | 5,350 | 1.1% |
| Axsome Therapeutics(AXSM) | COM | 05464T104 | $5.4K | 14,000 | 1.2% |
| Legend Biotech(LEGN) | SPONSORED ADS | 52490G102 | $5.6K | 4,500 | 1.3% |
| Fate Therapeutics(FATE) | COM | 31189P102 | $5.6K | 28,000 | 1.3% |
| Jazz Pharms.(JAZZ) | SHS USD | G50871105 | $5.9K | 17,200 | 1.3% |
| Horizon Therapeutics | SHS | G4617B105 | $7.5K | 183,473 | 1.7% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $7.6K | 31,500 | 1.7% |
| Avadel Pharms. | sponsored ADR | 05337M104 | $7.6K | 50,000 | 1.7% |
| Denali Therapeutics(DNLI) | COM | 24823R105 | $8.2K | 38,000 | 1.8% |